PHARCO |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.35 EUR | -.--% |
|
-.--% | -.--% |
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Karel Goderis
BRD | Director/Board Member | - | - |
Guy Wyvekens
BRD | Director/Board Member | - | - |
Pharco specializes in developing and marketing OTC products. The group's activity is organized around 3 families of products:
- nutritional therapy products;
- para-pharmaceutical products;
- phyto-therapeutic products.
All sales are in Belgium.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +19.95% | 42.78B | |
| +18.59% | 22.25B | |
| +13.93% | 14.39B | |
| +11.88% | 13.55B | |
| +35.58% | 11.27B | |
| -9.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.29% | 5.01B |
- Stock Market
- Equities
- PHAR Stock
